Stock AGR ASSURA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Assura Plc

Equities

AGR

GB00BVGBWW93

Real-time Estimate Cboe Europe
Other stock markets
 03:18:06 2024-04-19 am EDT 		5-day change 1st Jan Change
40.61 GBX -0.12% Intraday chart for Assura Plc -1.75% -15.88%
Apr. 12 JPMorgan raises Taylor Wimpey, Persimmon AN
Mar. 20 Which Powell will we get? Our Logo

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The firm trades with high earnings multiples: 40.66 times its 2024 earnings per share.
  • Based on current prices, the company has particularly high valuation levels.
  • For the past year, analysts have significantly revised downwards their profit estimates.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
ASSURA PLC Stock Assura Plc
-15.88% 1.52B
C+
WELLTOWER INC. Stock Welltower Inc.
+0.71% 53.67B
A-
VENTAS, INC. Stock Ventas, Inc.
-14.45% 17.17B
A-
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-9.04% 12.78B
A
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
-2.22% 7.35B
B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-19.97% 5.26B
B-
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+6.08% 3.2B
C-
AEDIFICA SA Stock Aedifica SA
-8.72% 2.93B
B+
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
+1.63% 3.02B
C
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+8.22% 2.62B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AGR Stock
  4. Ratings Assura Plc